Literature DB >> 4458862

Proceedings: Reduction of platelet monoamine oxidase activity in iron deficiency anaemia.

S Callender, D G Grahame-Smith, H F Woods, M B Youdim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4458862      PMCID: PMC1777012     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  6 in total

1.  Reduced monoamine oxidase activity in blood platelets from schizophrenic patients.

Authors:  D L Murphy; R J Wyatt
Journal:  Nature       Date:  1972-07-28       Impact factor: 49.962

2.  Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.

Authors:  D S Robinson; W Lovenberg; H Keiser; A Sjoerdsma
Journal:  Biochem Pharmacol       Date:  1968-01       Impact factor: 5.858

3.  Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients.

Authors:  D L Murphy; R Weiss
Journal:  Am J Psychiatry       Date:  1972-05       Impact factor: 18.112

4.  Decreased monoamine oxidase activity in liver of iron-deficient rats.

Authors:  A L Symes; T L Sourkes; M B Youdim; G Gregoriadis; H Birnbaum
Journal:  Can J Biochem       Date:  1969-11

5.  Properties of purified, soluble monoamine oxidase.

Authors:  M B Youdim; T L Sourkes
Journal:  Can J Biochem       Date:  1966-10

6.  Iron- and riboflavin-dependent metabolism of a monamine in the rat in vivo.

Authors:  A L Symes; K Missala; T L Sourkes
Journal:  Science       Date:  1971-10-08       Impact factor: 47.728

  6 in total
  2 in total

1.  Low iron storage in children with tilt positive neurally mediated syncope.

Authors:  Baris Guven; Taliha Oner; Vedide Tavli; Murat Muhtar Yilmazer; Savas Demirpence; Timur Mese
Journal:  World J Pediatr       Date:  2012-12-29       Impact factor: 2.764

2.  Vitamin B12-induced reduction of platelet monoamine oxidase activity in patients with dementia and pernicious anaemia.

Authors:  B Regland; C G Gottfries; L Oreland
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.